Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03293758 · ClinicalTrials.gov registry record
Food and Microbiome Longitudinal Investigation (FAMiLI)
A clinical trial of Cancer and Cardiovascular Diseases, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 16,000
- Enrollment target
- 1
- Study location
NCT03293758: Recruiting study of Cancer and Cardiovascular Diseases, sponsored by NYU Langone Health.
NCT03293758 is a study of Cancer and Cardiovascular Diseases that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 16,000 participants, above the 3,465-participant average among 615 other Cancer trials with a reported enrollment target (362% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03293758, a study of Cancer and Cardiovascular Diseases, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 16,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease
Primary Outcome
sex, race, education, oral health status, lifestyle, medical history, anthropometry, and medication use will be collected using the baseline questionnaire at enrolment. The collected information will provide risk stratification information for statistical control in studies of colorectal tumors and other major chronic diseases.
Conditions Studied
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16,000 participants |
| Start Date | 2016-05-16 |
| Est. Completion | 2034-12-31 |
What NCT03293758 shows while recruiting
NCT03293758 is an observational study that tracks outcomes without assigning an intervention. Its 16,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,465-participant average among 615 other Cancer trials with a reported enrollment target (362% higher).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03293758 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03293758 about?
NCT03293758 is a clinical study titled "Food and Microbiome Longitudinal Investigation (FAMiLI)". The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease
What is the current status of trial NCT03293758?
This trial is currently recruiting. The enrollment target is 16,000 participants. The study started on 2016-05-16. Estimated completion is 2034-12-31.
What conditions does trial NCT03293758 study?
This clinical trial studies the following conditions: Cancer, Cardiovascular Diseases.
Who is sponsoring clinical trial NCT03293758?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03293758 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03293758's enrollment target sits among peer trials
16,000 19th of 615 higher than 597 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01737528 · 16,000 participants
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
- NCT06380114 · 16,000 participants · NA
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
- NCT05447806 · 15,732 participants · NA
Diabetes Clinical Decision Support
- NCT06951867 · 16,640 participants
Tezspire Cardiac Events PASS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI